Hem › Virusinfektioner
Kliniska studier för Virusinfektioner som rekryterar i USA
31 studier för Virusinfektioner rekryterar deltagare vid platser över hela USA.
Städer med flest studier
- Washington, DC12 studier
- Houston, TX6 studier
- Boston, MA6 studier
- Baltimore, MD5 studier
- Hialeah, FL5 studier
- Columbus, OH4 studier
- Dallas, TX4 studier
- Atlanta, GA4 studier
- Cincinnati, OH4 studier
- San Francisco, CA3 studier
- St. Louis, MO3 studier
- Omaha, NE3 studier
- Miami, FL3 studier
- Tampa, FL3 studier
- Boise, ID3 studier
- Los Angeles, CA3 studier
- Worcester, MA3 studier
- Durham, NC3 studier
- Salt Lake City, UT3 studier
- New York City, NY3 studier
Efter delstat
- Alabama3 studier
- Colorado3 studier
- District of Columbia5 studier
- Florida6 studier
- Georgia5 studier
- Idaho3 studier
- Illinois3 studier
- Kalifornien11 studier
- Kentucky3 studier
- Louisiana3 studier
- Maryland14 studier
- Massachusetts6 studier
- Michigan3 studier
- Missouri4 studier
- Nebraska3 studier
- New York6 studier
- North Carolina5 studier
- Ohio9 studier
- Pennsylvania5 studier
- South Carolina3 studier
- Texas9 studier
- Utah4 studier
- Virginia4 studier
Nyligen uppdaterade studier
Officiell studietext (engelska)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT05624450A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 29 sep. 2026 · NCT07214571Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
RekryterarObservationsstudie
Ålder 18 till 120 · Alla kön · Uppdaterad 28 sep. 2026 · NCT00006518The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
RekryterarObservationsstudie
Ålder 2 till 100 · Alla kön · Uppdaterad 28 sep. 2026 · NCT01011712A Study of COVID-19 Vaccine(s) in Children and Adults
RekryterarFas 3Friska volontärer välkomna
Ålder 5 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT07798648A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
RekryterarFas 3
Ålder 12 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06679140A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07013474Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection
RekryterarFas 1Friska volontärer välkomna
Ålder 18 till 50 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07706686Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions
RekryterarFas 2
Ålder 18 till 65 · Alla kön · Uppdaterad 24 sep. 2026 · NCT07654283A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health
RekryterarFas 1Friska volontärer välkomna
Ålder 18 till 50 · Alla kön · Uppdaterad 21 sep. 2026 · NCT07565090Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults
RekryterarFas 1Friska volontärer välkomna
Ålder 18 till 50 · Alla kön · Uppdaterad 15 sep. 2026 · NCT06863142Viral Infections in Healthy and Immunocompromised Hosts
RekryterarObservationsstudieFriska volontärer välkomna
6 Months – 120 Years · Alla kön · Uppdaterad 14 sep. 2026 · NCT01306084Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity
RekryterarObservationsstudieFriska volontärer välkomna
2 Months – 115 Years · Alla kön · Uppdaterad 10 sep. 2026 · NCT04419870HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
RekryterarFas 1
36 Months – 22 Years · Alla kön · Uppdaterad 4 sep. 2026 · NCT03911388Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells for Viral Infections After Stem Cell Transplant
RekryterarFas 2
Alla åldrar · Alla kön · Uppdaterad 4 sep. 2026 · NCT04230356Donor-Derived Viral Specific T-cells (VSTs)
RekryterarFas 1/2
4 Weeks · Alla kön · Uppdaterad 4 sep. 2026 · NCT02048332Third Party Viral Specific T-cells (VSTs)
RekryterarFas 2
2 Days · Alla kön · Uppdaterad 4 sep. 2026 · NCT02532452A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses
RekryterarFas 1/2Friska volontärer välkomna
Ålder 40 till 64 · Alla kön · Uppdaterad 18 aug. 2026 · NCT06810934A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
RekryterarFas 4Friska volontärer välkomna
Ålder 18 till 64 · Alla kön · Uppdaterad 7 aug. 2026 · NCT07730450Genetic Studies of Chronic Active Epstein-Barr Disease
RekryterarObservationsstudie
Ålder 1 till 120 · Alla kön · Uppdaterad 28 juli 2026 · NCT00032513TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
RekryterarFas 1
Alla åldrar · Alla kön · Uppdaterad 11 juni 2026 · NCT04013802Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)
RekryterarFas 1/2
1 Month – 79 Years · Alla kön · Uppdaterad 15 apr. 2026 · NCT04197596A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
RekryterarFas 4Friska volontärer välkomna
6 Months · Alla kön · Uppdaterad 27 mars 2026 · NCT06585241Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 30 jan. 2026 · NCT07110636Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts
RekryterarFas 1
3 Months – 80 Years · Alla kön · Uppdaterad 26 jan. 2026 · NCT04691622Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.